je.st
news
Gilead says hepatitis C treatment's approval is on track
2013-01-07 19:30:14| Biotech - Topix.net
Gilead Sciences is on track to file for regulatory approval of sofosbuvir, its treatment for chronic hepatitis C virus infection, starting in mid-2013, the Foster City biotech company said on Monday.
Tags: on
track
approval
treatments
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||